Загрузка...
Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?
OBJECTIVES: To examine whether blood pressure reductions differ by estrogen use among overweight glucose-intolerant women. METHODS: We conducted a secondary analysis of postmenopausal Diabetes Prevention Program participants who used oral estrogen with or without progestogen at baseline and at 1-yea...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3858523/ https://ncbi.nlm.nih.gov/pubmed/23942251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0b013e3182a0e3ea |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|